Targeting wild-type IDH1 sensitizes homologous recombination proficient pancreatic cancer to PARP inhibition

被引：0
|
作者：
Zarei, Mehrdad
Hajihassani, Omid
Graor, Hallie J.
Tahhan, Soubhi
Loftus, Alexander W.
Nakazzi, Faith
Ali, Semmer A.
Naji, Parnian
Rothermel, Luke D.
Brody, Jonothan R.
Winter, Jordan M.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 17期
关键词：
D O I：
10.1158/1538-7445.PANCREATIC24-C046
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
C046
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Targeting wild-type IDH1 enhances chemosensitivity in pancreatic cancer
    Zarei, Mehrdad
    Hajihassani, Omid
    Hue, Jonathan J.
    Graor, Hallie J.
    Hajihassani, Arian
    Loftus, Alexander W.
    Rothermel, Luke D.
    Winter, Jordan M.
    CANCER RESEARCH, 2023, 83 (07)
  • [2] Inhibition of IDH1 impairs homologous recombination and induces sensitivity to PARP inhibitor in pancreatic cancer
    Zarei, Mehrdad
    Hajihassani, Omid
    Graor, Hallie J.
    Loftus, Alexander W.
    Tahhan, Soubhi
    Nakazzi, Faith
    Naji, Parnian
    Rothermel, Luke D.
    Brody, Jonothan R.
    Winter, Jordan M.
    CANCER RESEARCH, 2024, 84 (06)
  • [3] Wild-type IDH1 inhibition enhances chemotherapy response in pancreatic cancer
    Zarei, Mehrdad
    Hajihassani, Omid
    Hue, Jonathan J.
    Graor, Hallie J.
    Loftus, Alexander W.
    Rothermel, Luke D.
    Winter, Jordan M.
    CANCER RESEARCH, 2024, 84 (02)
  • [4] Arsenic compound sensitizes homologous recombination proficient ovarian cancer to PARP inhibitors
    Xu, Junfen
    Shen, Yuanming
    Wang, Conghui
    Tang, Sangsang
    Hong, Shiyuan
    Lu, Weiguo
    Xie, Xing
    Cheng, Xiaodong
    CELL DEATH DISCOVERY, 2021, 7 (01)
  • [5] Arsenic compound sensitizes homologous recombination proficient ovarian cancer to PARP inhibitors
    Junfen Xu
    Yuanming Shen
    Conghui Wang
    Sangsang Tang
    Shiyuan Hong
    Weiguo Lu
    Xing Xie
    Xiaodong Cheng
    Cell Death Discovery, 7
  • [6] Repression of BET activity sensitizes homologous recombination-proficient cancers to PARP inhibition
    Yang, Lu
    Zhang, Youyou
    Shan, Weiwei
    Hu, Zhongyi
    Yuan, Jiao
    Pi, Jingjiang
    Wang, Yueying
    Fan, Lingling
    Tang, Zhaoqing
    Li, Chunsheng
    Hu, Xiaowen
    Tanyi, Janos L.
    Fan, Yi
    Huang, Qihong
    Montone, Kathleen
    Dang, Chi V.
    Zhang, Lin
    SCIENCE TRANSLATIONAL MEDICINE, 2017, 9 (400)
  • [7] Combining PARP inhibition with radiation to sensitize homologous recombination proficient pancreatic cancer to immunotherapy.
    Zhang, Qiang
    Jiang, Long
    Zheng, Yawen
    Lawrence, Theodore
    Sahai, Vaibhav
    Green, Michael D.
    Morgan, Meredith
    CLINICAL CANCER RESEARCH, 2021, 27 (08)
  • [8] Wild-type IDH1 inhibition enhances chemotherapy response in melanoma
    Zarei, Mehrdad
    Hajihassani, Omid
    Hue, Jonathan J.
    Graor, Hallie J.
    Loftus, Alexander W.
    Rathore, Moeez
    Vaziri-Gohar, Ali
    Asara, John M.
    Winter, Jordan M.
    Rothermel, Luke D.
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
  • [9] Wild-type IDH1: A molecular target in IDH1 mutant cancers
    Wickenden, Julie A.
    Russell, Paul
    Smith, Amy
    Henley, Tom
    Elliott, Jane
    Gitterman, Dan
    Stockdale, Mark
    Schofield, Christine
    Torrance, Chris
    Moore, Jonathan D.
    CANCER RESEARCH, 2014, 74 (19)
  • [10] Wild-type IDH1 inhibition enhances chemotherapy response in melanoma
    Mehrdad Zarei
    Omid Hajihassani
    Jonathan J. Hue
    Hallie J. Graor
    Alexander W. Loftus
    Moeez Rathore
    Ali Vaziri-Gohar
    John M. Asara
    Jordan M. Winter
    Luke D. Rothermel
    Journal of Experimental & Clinical Cancer Research, 41
12345